Press Release

Aug, 25 2023

Unlocking Precision in Allergy Diagnosis: Pioneering Solutions for a Symptom-Free Future

According to the world health organization (WHO), around 80% of the global population resides in cities, making air quality a critical concern, especially in low-income nations. Rising global allergy prevalence and demand for accurate allergy detection fuel market expansion. Innovative tests such as allergen-specific IgE assays, skin tests, and molecular diagnostics contribute to precise and early diagnosis. Early and accurate diagnosis, alongside prevention and curative therapies, are crucial unmet needs in managing allergies, and skin to chronic diseases.

Access Full Report at

Data Bridge Market Research analyses that the India Allergy Diagnostics Market is expected to grow at USD 4.25 billion in 2021, would rocket up to USD 9.72 billion by 2029, and is expected to undergo a CAGR of 10.9% during the forecast period 2022 to 2029. The growing trend of personalized medicine, which includes tailored treatment plans based on individual allergies, has increased the demand for accurate and precise allergy diagnostics.

Key Findings of the Study

India Allergy Diagnostics Market

Rising healthcare infrastructure is expected to drive the market's growth rate

The improvement in healthcare infrastructure and the expansion of diagnostic facilities in India has significantly contributed to the accessibility and availability of allergy diagnostic tests. The increased number of healthcare centers, hospitals, and clinics equipped with advanced diagnostic technologies allows for easier access to allergy testing services across different regions in the country. This enhancement in healthcare infrastructure has played a crucial role in the early detection and management of allergies, leading to better patient outcomes and improved healthcare services.

Report Scope and Market Segmentation

Report Metric


Forecast Period

2022 to 2029

Base Year


Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Products and Services (Assay Kits, Instruments, Consumables and Services), Allergen (Inhaled Allergens, Food Allergens, Antibiotics, Other Drugs and Chemicals Allergens, Occupational Allergens, Miscellaneous Plant Allergens, Contact Allergens And Others), Test (In-Vitro Test and In-Vivo Test), End User (Hospitals, Diagnostic Laboratories, Academic Research Laboratories and Others), Distribution Channel (Direct and Indirect)

Market Players Covered

Thermo Fisher Scientific Inc., (U.S.), Siemens Healthcare GmbH (Germany), Danaher (U.S.), Omega Diagnostics Group PLC (U.K.), bioMérieux (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (U.S.), NEOGEN Corporation (U.S.), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (U.S.), Stallergenes Greer (U.K.), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (U.S.), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (U.S.), Lincoln Diagnostics, Inc. (U.S.), Astra Biotech GmbH (Germany), and Erba Group (U.K.)

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The India allergy diagnostics market is segmented on the basis of products and services, allergen, test, end user, and distribution channel

  • On the basis of products and services, the India allergy diagnostics market is segmented into assay kits, instruments, consumables, and services
  • On the basis of allergen, the India allergy diagnostics market is segmented into inhaled allergens, food allergens, antibiotics, other drugs and chemicals allergens, occupational allergens, miscellaneous plant allergens, contact allergens, and others
  • On the basis of test, the India allergy diagnostics market is segmented into in-vitro test and in-vivo test
  • On the basis of end user, the India allergy diagnostics market is segmented into hospitals, diagnostic laboratories, academic research laboratories, and others
  • On the basis of distribution channel, the India allergy diagnostics market is segmented into direct and indirect.

Major Players

Data Bridge Market Research recognizes the following companies as the major India allergy diagnostics market players in India allergy diagnostics market are bioMérieux (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (U.S.), NEOGEN Corporation (U.S.), Eurofins Scientific (Luxembourg)

India Allergy Diagnostics Market

Market Developments

  • In 2022, Reacta Healthcare, a UK-based company, secured its first U.S. patent for food allergy treatment or challenge meals used in oral food challenges (OFCs). The company already held patents across Europe, Hong Kong, Canada, Australia and UK. This development is expected to play a vital role in taking the U.S. business growth in the coming years.
  • In 2021, Hitachi Chemical Diagnostics, Inc. has been replaced by Minaris Medical America, Inc. Uniting the medical business group firms under the Minaris Medical brand, Hitachi wants to boost its global position and increase commercial activities in the field of in-vitro diagnostics. Both companies are owned by Showa Denko Materials Co., Ltd.
  • In 2021, PerkinElmer Inc. has reached an agreement to purchase Immunodiagnostic Systems Holdings PLC. PerkinElmer Inc. will be able to strengthen its position in the ImmunoDiagnostics (IDS) industry as a result of the acquisition. EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, a firm that sells allergy products and services, will take over IDS.
  • In 2020, NEOGEN Corporation introduced Reveal 3-D for Gluten, a rapid and accurate diagnostic test. It allows users to detect gluten in food and environmental samples, offering a reliable solution for gluten sensitivity and celiac disease management.
  • In 2019, Romer Labs Division Holding GmbH opened its APAC Solutions Centre in Singapore. The APAC Solutions Centre features new facilities for food allergen testing.

For more detailed information about the India allergy diagnostics market report, click here –

Client Testimonials